BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND ZRSR2, URP, 8233, ENSG00000169249, U2AF1RS2, MGC142040, U2AF1L2, U2AF1-RS2, MGC142014 AND Diagnosis
11 results:

  • 1. Mutational Landscape of Patients Referred for Elevated Hemoglobin Level.
    Bhai P; Chin-Yee B; Pope V; Cheong I; Matyashin M; Levy MA; Foroutan A; Stuart A; Hsia CC; Lin H; Sadikovic B; Chin-Yee I
    Curr Oncol; 2022 Sep; 29(10):7209-7217. PubMed ID: 36290845
    [No Abstract]    [Full Text] [Related]  

  • 2. Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients.
    Khanlari M; Yin CC; Takahashi K; Lachowiez C; Tang G; Loghavi S; Bah I; Wang W; Konoplev S; Medeiros LJ; Pemmaraju N; Khoury JD; Wang SA
    Leukemia; 2022 May; 36(5):1343-1350. PubMed ID: 35279700
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The Genetics of Myelodysplastic Syndromes: Clinical Relevance.
    Chiereghin C; Travaglino E; Zampini M; Saba E; Saitta C; Riva E; Bersanelli M; Della Porta MG
    Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440317
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes.
    Nazha A; Hu ZH; Wang T; Lindsley RC; Abdel-Azim H; Aljurf M; Bacher U; Bashey A; Cahn JY; Cerny J; Copelan E; DeFilipp Z; Diaz MA; Farhadfar N; Gadalla SM; Gale RP; George B; Gergis U; Grunwald MR; Hamilton B; Hashmi S; Hildebrandt GC; Inamoto Y; Kalaycio M; Kamble RT; Kharfan-Dabaja MA; Lazarus HM; Liesveld JL; Litzow MR; Majhail NS; Murthy HS; Nathan S; Nishihori T; Pawarode A; Rizzieri D; Sabloff M; Savani BN; Schachter L; Schouten HC; Seo S; Shah NN; Solh M; Valcárcel D; Vij R; Warlick E; Wirk B; Wood WA; Yared JA; Alyea E; Popat U; Sobecks RM; Scott BL; Nakamura R; Saber W
    Biol Blood Marrow Transplant; 2020 Nov; 26(11):2139-2146. PubMed ID: 32781289
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Effect of Signal Transduction Pathway Gene Mutations on the One- course Induced Remission Rate and Analysis of Clinical Characteristics in Patients with CBF-AML].
    Fan LF; Xu J; Chen XH; Tian TT; Xie J; Hu JJ; Guo ZP; Tan YH; Xu ZF; Ren FG; Zhang YF; Luo M; Ren WX; Wang HW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):781-788. PubMed ID: 32552936
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Additional gene mutations may refine the 2017 European leukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years.
    Eisfeld AK; Kohlschmidt J; Mims A; Nicolet D; Walker CJ; Blachly JS; Carroll AJ; Papaioannou D; Kolitz JE; Powell BE; Stone RM; de la Chapelle A; Byrd JC; Mrózek K; Bloomfield CD
    Leukemia; 2020 Dec; 34(12):3215-3227. PubMed ID: 32461631
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinicopathologic characterisation of myeloid neoplasms with concurrent spliceosome mutations and myeloproliferative-neoplasm-associated mutations.
    Liu YC; Illar GM; Bailey NG
    J Clin Pathol; 2020 Nov; 73(11):728-736. PubMed ID: 32217616
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Refractory macrocytic anemias in patients with clonal hematopoietic disorders and isolated mutations of the spliceosome gene zrsr2.
    Fleischman RA; Stockton SS; Cogle CR
    Leuk Res; 2017 Oct; 61():104-107. PubMed ID: 28942350
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identifying large indels in targeted next generation sequencing assays for myeloid neoplasms: a cautionary tale of the
    Ng IK; Ng C; Low JJ; Chiu L; Seah E; Ng CH; Chng WJ; Yan B; Ban KHK
    J Clin Pathol; 2017 Dec; 70(12):1069-1073. PubMed ID: 28676493
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.
    Lindsley RC; Mar BG; Mazzola E; Grauman PV; Shareef S; Allen SL; Pigneux A; Wetzler M; Stuart RK; Erba HP; Damon LE; Powell BL; Lindeman N; Steensma DP; Wadleigh M; DeAngelo DJ; Neuberg D; Stone RM; Ebert BL
    Blood; 2015 Feb; 125(9):1367-76. PubMed ID: 25550361
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status.
    Schmidt M; Rinke J; Schäfer V; Schnittger S; Kohlmann A; Obstfelder E; Kunert C; Ziermann J; Winkelmann N; Eigendorff E; Haferlach T; Haferlach C; Hochhaus A; Ernst T
    Leukemia; 2014 Dec; 28(12):2292-9. PubMed ID: 25212276
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.